Pure Global
NCT06236347

Rural COPD E-Visit Study

Scale and Evaluate Smoking Cessation and COPD Screening E-Visits to Rural Health Clinics
Medical University of South Carolina·ClinicalTrials.gov·behavioralEnrolling by invitation
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Smoking Cessation
Drug/Device/Intervention
Smoking cessation e-visit
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Medical University of South Carolina
Location
Charleston, United States of America
Timeline & enrollment
Phase
N/A
Start date
Mar 19, 2024
End date
Feb 01, 2027
Enrollment
144 participants
Primary outcome

Smoking Cessation,Smoking Cessation,Smoking Cessation,Reduction in Cigarettes Per Day,Reduction in Cigarettes Per Day,Reduction in Cigarettes Per Day

Summary

The purpose of this study is to evaluate an electronic visit (e-visit) for COPD screening and
 for quitting smoking. Participants will be randomly assigned to receive either the smoking
 cessation e-visit or not. The e-visit will look similar to an online questionnaire asking
 about smoking history, preferences for cessation medications, and chronic COPD symptoms.
 Participants may receive a prescription for a smoking cessation medication as an outcome of
 the e-visit, if randomized to the e-visit group, but there is no requirement to take any
 medication. This study consists of questionnaires and breath samples provided at 4 separate
 time points throughout the study. Participation in this study will take about 24 weeks.

ICD-10 classifications
Mental and behavioural disorders due to use of tobacco withdrawal stateTobacco useExposure to tobacco smokeToxic effect: Tobacco and nicotineMental and behavioural disorders due to use of tobacco
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06236347
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06236347 through Pure Global AI's free database. This phase not specified trial is sponsored by Medical University of South Carolina and is currently Enrolling by invitation. The study focuses on Smoking Cessation. Target enrollment is 144 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.